Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


30.07.2018

1 Am J Gastroenterol
1 Gastroenterol Hepatol
2 Gastroenterology
5 J Viral Hepat
1 J Virol
2 Lancet Gastroenterol Hepatol
6 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. REDMAN JS, Sterling RK
    Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.
    Am J Gastroenterol. 2018 Jul 24. pii: 10.1038/s41395-018-0201.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  2. MIRANDA-BAUTISTA J, Menchen L
    Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191.
    PubMed     Text format    


    Gastroenterology

  3. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Text format     Abstract available

  4. LUNEMANN S, Schobel A, Kah J, Fittje P, et al
    Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
    Gastroenterology. 2018 Jul 19. pii: S0016-5085(18)34785.
    PubMed     Text format     Abstract available


    J Viral Hepat

  5. PINTILIE H, Brook G
    Commentary: A review of risk of hepatitis B and C transmission through biting or spitting.
    J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12976.
    PubMed     Text format     Abstract available

  6. SCOTT N, Sacks-Davis R, Pedrana A, Doyle J, et al
    Eliminating hepatitis C: the importance of frequent testing of people who inject drugs in high prevalence settings.
    J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12975.
    PubMed     Text format     Abstract available

  7. BILOUNGA NDONGO C, Eteki L, Siedner M, Mbaye R, et al
    Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey.
    J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12974.
    PubMed     Text format     Abstract available

  8. SUGIURA A, Joshita S, Umemura T, Yamazaki T, et al
    Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
    J Viral Hepat. 2018 Jul 25. doi: 10.1111/jvh.12973.
    PubMed     Text format     Abstract available

  9. DARVISHIAN M, Janjua NZ, Chong M, Cook D, et al
    Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.
    J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12977.
    PubMed     Text format     Abstract available


    J Virol

  10. NYSTROM K, Wanrooij PH, Waldenstrom J, Adamek L, et al
    INOSINE TRIPHOSPHATE PYROPHOSPHATASE DEPHOSPHORYLATES RIBAVIRIN TRIPHOSPHATE AND REDUCED ENZYMATIC ACTIVITY POTENTIATES MUTAGENESIS IN HEPATITIS C VIRUS.
    J Virol. 2018 Jul 25. pii: JVI.01087-18. doi: 10.1128/JVI.01087.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  11. ASSELAH T
    A village without hepatitis C in Egypt: will micro-elimination lead to macro-elimination?
    Lancet Gastroenterol Hepatol. 2018 Jul 17. pii: S2468-1253(18)30178.
    PubMed     Text format    

  12. SHIHA G, Metwally AM, Soliman R, Elbasiony M, et al
    An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
    Lancet Gastroenterol Hepatol. 2018 Jul 17. pii: S2468-1253(18)30139.
    PubMed     Text format     Abstract available


    PLoS One

  13. EVANS H, Balasegaram S, Douthwaite S, Hunter L, et al
    An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    PLoS One. 2018;13:e0198520.
    PubMed     Text format     Abstract available

  14. XIONG QF, Xiong T, Huang P, Zhong YD, et al
    Early predictors of acute hepatitis B progression to liver failure.
    PLoS One. 2018;13:e0201049.
    PubMed     Text format     Abstract available

  15. SOOD A, Suryaprasad A, Trickey A, Kanchi S, et al
    The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey.
    PLoS One. 2018;13:e0200461.
    PubMed     Text format     Abstract available

  16. CUYPERS L, Perez AB, Chueca N, Aldamiz-Echevarria T, et al
    Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.
    PLoS One. 2018;13:e0201268.
    PubMed     Text format     Abstract available

  17. MOTOYAMA H, Tamori A, Kubo S, Uchida-Kobayashi S, et al
    Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    PLoS One. 2018;13:e0201423.
    PubMed     Text format     Abstract available

  18. TAT TRUNG N, Duong DC, Tong HV, Hien TTT, et al
    Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    PLoS One. 2018;13:e0196081.
    PubMed     Text format     Abstract available


    PLoS Pathog

  19. DRAPPIER M, Jha BK, Stone S, Elliott R, et al
    A novel mechanism of RNase L inhibition: Theiler's virus L* protein prevents 2-5A from binding to RNase L.
    PLoS Pathog. 2018;14:e1006989.
    PubMed     Text format     Abstract available

  20. SHANMUGAM S, Nichols AK, Saravanabalaji D, Welsch C, et al
    HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A.
    PLoS Pathog. 2018;14:e1007177.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  21. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
    RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
    PubMed     Text format     Abstract available


    Virology

  22. HUMES D, Ramirez S, Jensen TB, Li YP, et al
    Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Virology. 2018;522:177-192.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: